In Partisan U.S. House, Consensus Emerges Over Manufacturer 340B Actions

Note from Publisher and CEO Ted Slafsky: I encourage you to read today’s sponsored content article from 340B Report sponsor Trellis Rx about a Sept. 22 panel discussion on recent manufacturer actions in the contract pharmacy space as well as mitigation strategies. I will provide an update on the latest policy developments and discuss what might happen next. Trellis Rx CEO Andy Maurer and Chief Pharmacy Officer Jerry Buller will discuss its potential impact on patients and providers and how to address these challenges. You can learn more and register below.

BREAKING: Hospital Groups Ask Full U.S. Appeals Court to Rehear 340B Lawsuit

The American Hospital Association, the Association of American Medical Colleges, America’s Essential Hospitals, and three health systems have asked a federal appeals court in Washington, D.C., to reconsider a three-judge appellate panel’s July 31 decision upholding the Trump administration’s nearly 30 percent cut since 2018 in 340B hospitals’ drug reimbursement under the hospital outpatient prospective payment system (OPPS). We will report in greater depth soon about the request for a rehearing.

.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer